Bone and Mineral 1991: Vol 13 Index

5 Pages·1991·0.84 MB·English

Author Index
Baylink D.J., see Grecu, E.O., 153 Fuss, M., Pepersack, T., Corvilain, J., Berg-
Baylink, D.J., see Zhang, R.W., 201 mann, P., Willems, D., Simon, J. and
Bellack, U., see Stanka, P., 93 Body, J.J. Stimulation of calcitonin se-
Bellows, C.G., see Laschinger, C.A., 23 cretion by an oral calcium load test in
Bergmann, P., see Fuss, M., 131 normal subjects and in idiopathic renal
Blake, G.M., see Wilson, C.R., 69 stone formers, 131
Body, J.J., see Fuss, M., 131
Bousfield, G.R., see Mizuno, M., 1 Gommers, D., see Trouerbach, W.T., 55
Brunn, J.C., see Mizuno, M., 1 Goodsitt, M.M., Johnson, R.H. and Chesnut
Butler, W.T., see Kasugai, S., 235 III, C.H. A new set of calibration stan-
Butler, W.T., see Mizuno, M., 1 dards for estimating the fat and mineral
content of vertebrae via dual energy
Chesnut III, C.H., see Goodsitt, M.M., 217 QCT, 217
Corvilain, J., see Fuss, M., 131 Goulding, A. and Fisher, L. 17f-Estradiol
Cottini, E., see Fiore, C.E., 77 protects rats from osteopenia associated
Crowther, R.S., see Zhang, R.W., 201 with administration of the luteinising
hormone releasing hormone (LHRH)
De Man, S.A., see Trouerbach, W.T., 55 agonist, buserelin, 47
Di Salvo, G., see Fiore, C.E., 77 Grecu, E.O., Simmons, R., Baylink, D.J.,
Haloran, B.P. and Spencer, M.E. Ef-
Farach-Carson, M.C., see Mizuno, M., 1 fects of medroxyprogesterone acetate
Fargetta, C., see Fiore, C.E., 77 on some parameters of calcium metab-
Fiore, C.E., Cottini, E., Fargetta, C., Di olism in patients with glucocorticoid-
Salvo, G., Foti, R. and Raspagliesi, M. induced osteoporosis, 153
The effects of muscle-building exercise Grobbee, D.E., see Trouerbach, W.T., 55
on forearm bone mineral content and
osteoblast activity in drug-free and ana- Haloran, B.P., see Grecu, E.O., 153
bolic steroids self-administering young Hazenberg, G.J., see Van der Wiel, H.E., 123
men, 77
Fisher, L., see Goulding, A., 47 Johnson, R.H., see Goodsitt, M.M., 217
Fogelman, I., see Wilson, C.R., 69
Forwood, M.R. and Parker, A.W. Repetitive Karonen, S.-L., see Laitinen, K., 139
loading, in vivo, ofthe tibiae and fem- Kasugai, S., Zhang, Q., Overall, C.M.,
ora of rats: effects of repeated bouts of Wrana, J.L., Butler, W.T. and Sodek,
treadmill-running, 35 J. Differential regulation of the 55 and
Foti, R., see Fiore, C.E., 77 44 kDa forms of secreted phosphopro-
Fujisawa, R., see Mizuno, M., 1 tein 1 (SPP-1, osteopontin) in normal
and transformed rat bone cells by Pinero, G.J., see Mizuno, M., 1
osteotropic hormones, growth factors Poéschl, B., see Schénfeld, H.-J., 171
and a tumor promoter, 235
Kistler, A., see Schonfeld, H.-J., 171 Ramp, W.K. and Yancey, J.M. P values and
KtYosowska, B., see Wrzoflkowa, T., 111 their problems, 163
Raspagliesi, M., see Fiore, C.E., 77
Laitinen, K., Lamberg-Allardt, C., Tunninen, Rodin, A., see Wilson, C.R., 69
R., Karonen, S.-L., Ylikahri, R. and Rudzinka-Kisiel, T., see Wrzofkowa, T., 111
Valimaki, M. Effects of 3 weeks’ mod-
erate alcohol intake on bone and min- Scharla, $.H., see Lempert, U.G., 103
eral metabolism in normal men, 139 Schonfeld, H.-J., Péschl, B., Wessner, B. and
Lamberg-Allardt, C., see Laitinen, K., 139 Kistler, A. Altered differentiation of
Laschinger, C.A., Bellows, C.G. and Wasi, S. limb bud cells by transforming growth
Modulation of plasminogen activators factors-6 isolated from bone matrix and
and plasminogen activator inhibitors by from platelets, 171
TGF-f, IL-la and EGF in fetal rat cal- Seyer, J.M., see Mizuno, M., 1
varia cells at different times of culture, Simmons, D.J., see Zhang, R.W., 201
23 Simmons, R., see Grecu, E.O., 153
Lempert, U.G., Scharla, S.H., Minne, H.W. Simon, J., see Fuss, M., 131
and Ziegler, R. Influence of parathy- Sodek, J., see Kasugai, S., 235
roidectomy, 1,25-dihydroxyvitamin D, Spencer, M.E., see Grecu, E.O., 153
and high dietary calcium intake on de- Stanka, P., Bellack, U. and Lindner, A. On
mineralized bone matrix powder- the morphology of the terminal micro-
induced bone formation in the rat, 103 vasculature during endochondral ossifi-
Lindner, A., see Stanka, P., 93 cation in rats, 93
Lips, P., see Van der Wiel, H.E., 123
Trouerbach, W.T., de Man, S.A., Gommers,
Mark, M.P., see Mizuno, M., 1 D., Zwamborn, A.W. and Grobbee,
Minkin, C. and Yu, X.-h. Calcitonin receptor D.E. Determinants of bone mineral
expression and its regulation by 1a,25- content in childhood, 55
dihydroxyvitamin D, during de novo Tunninen, R., see Laitinen, K., 139
osteoclast formation in organ cultures
of fetal mouse metatarsals, 191 Valimaki, M., see Laitinen, K., 139
Minne, H.W., see Lempert, U.G., 103 Van der Wiel, H.E., Lips, P., Nauta, J., Nete-
Mizuno,M., Farach-Carson, M.C., Pinero, lenbos, J.C. and Hazenberg, G.J. Bio-
G.J., Fujisawa, R., Brunn, J.C., Seyer, chemical parameters of bone turnover
J.M., Bousfield, G.R., Mark, M.P. and during ten days of bed rest and subse-
Butler, W.T. Identification of the rat quent mobilization, 123
bone 60K acidic glycoprotein as a,HS-
glycoprotein, 1 Wasi, S., see Laschinger, C.A., 23
Mohan, S., see Zhang, R.W., 201 Wessner, B., see Schénfeld, H.-J., 171
Miiller, C., see Pietschmann, P., 251 Willems, D., see Fuss, M., 131
Wilson, C.R., Fogelman, I., Blake, G.M. and
Nauta, J., see Van der Wiel, H.E., 123 Rodin, A. The effect of positioning on
Netelenbos, J.C., see Van der Wiel, H.E., 123 dual energy X-ray bone densitometry
of the proximal femur, 69
Overall, C.M., see Kasugai, S., 235 Woloszczuk, W., see Pietschmann, P., 251
Wrana, J.L., see Kasugai, S., 235
Parker, A.W., see Forwood, M.R., 35 Wrzolkowa, T., MRudzinka-Kisiel, T. and
Pepersack, T., see Fuss, M., 131 KtYosowska, B. Calcium content of se-
Pietschmann, P., Miiller, C. and Woloszczuk, rum and myocardium in vitamin D-
W. Serum osteocalcin levels are de- induced cardionecrosis, 111
creased in patients with acute viral hep-
atitis, 251 Yancey, J.M., see Ramp, W.K., 163
Ylikahri, R., see Laitinen, K., 139 tion of marrow stromal cells to the reg-
Yu, X.-h., see Minkin, C., 191 ulation of osteoblast proliferation in
rats: evidence for the involvement of
Zhang, Q., see Kasugai, S., 235 insulin-like growth factors, 201
Zhang, R.W., Simmons, D.J., Crowther, R.S., Ziegler, R., see Lempert, U.G., 103
Mohan, S. and Baylink, D.J. Contribu- Zwamborn, A.W., see Trouerbach, W.T., 55
Subject Index
Adaptation, 35 Estrogen-deficiency bone loss, 47
Alkaline phosphatase, 201 Ethanol, 139
Anabolic steroids, 77 Exercise, 35
Angiogenesis, 93
Fat, 217
Bone, 69, 217 Fatigue-microdamage, 35
Bone formation, 103 Fetal rat calvarial cell, 235
Bone Gla protein, 77, 251
Bone growth, 35 Glucocorticoid-induced osteoporosis, 153
Bone mass, 77 Growth factor, 235
Bone matrix, 1, 171
Bone mineral content, 55 a,HS-Glycoprotein, 1
Bone mineral metabolism, 139 Hydroxyproline excretion, 123
Bone nodule, 23
Bone resorption, 123 Idiopathic urolithiasis, 131
Buserelin, 47 IL-la, 23
Immobilization, 123
Calcitonin, 131 Insulin-like growth factor, 201
Calcitonin receptor, 191
Calcium, 111 LHRH agonists, 47
Cardionecrosis, 111 Limb bud cells, 171
Children, 55 Lumbar disc protrusion, 123
Computed tomography (CT), 217
Concanavalin A, 235 Medroxyprogesterone acetate, 153
Mineralization, 69, 217
1,25-Dihydroxyvitamin D,, 103 Mouse bone, 191
Densitometry, 69
Dietary calcium, 103 1,25(OH),D,, 191
DNA synthesis, 201 Oral calcium load test, 131
Dual energy, 69 Organ culture, 191
Dual-energy CT, 217 Osteoblast, 1, 201
DXA, 69 Osteoblast activity, 153
Osteocalcin, 139, 251
EGF, 23 Osteoclasts, 191
Endochondral ossification, 93 Osteopontin, 235
Endothelial pockets, 93 Osteoporosis, 47, 123, 139
Retinoic acid, 235
Parathyroid hormone, 139, 235, 251 ROS 17/2.8 cell, 235
Parathyroidectomy, 103
Physical exercise, 77 Secreted phosphoprotein 1, 235
Plasminogen activator, 23 Skeletal age, 55
Plasminogen activator inhibitor, 23 Stromal cell, 201
Proximal femur, 69
TGF-, 23, 171
272
Quantitative réntgen microdensitometry, 55 Tumor promoter, 235
Rat, 111 Vira! hepatitis, 251
Rat calvaria cell, 23 Vitamin D, 111, 139
X-Ray absorptiometry, 69 Vitamin D,, 235
RCA 11 cell, 235